Rosenblatt Maintains Buy on Nutanix, Raises Price Target to $75

Benzinga Newsdesk www.benzinga.com Positive 79.3%

Neg 0% Neu 0% Pos 79.3%

Rosenblatt analyst Blair Abernethy maintains Nutanix (NASDAQ:NTNX) with a Buy and raises the price target from $60 to $75.